Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAY2927088 pharmacokinetics study in healthy male participants
NL-OMON60734Phase 1Completed
- Sponsor
- Bayer
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of sevabertinib, sponsored by Bayer. Started Jan 2024; status: completed.
02
Drugs
sevabertinib
Beyond the preview
Go deeper on NL-OMON60734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60734.